![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Cepheid Gets CE Mark for Two HIV Tests
Cepheid Gets CE Mark for Two HIV Tests
![CE mark](https://www.fdanews.com/ext/resources/images/ce-mark.gif?t=1627682539&width=430)
August 2, 2021
Sunnyvale, Calif.-based Cepheid has received a CE mark for two HIV-1 tests: the Xpert HIV-1 Viral Load XC and Xpert HIV-1 Qual XC.
The tests can identify HIV viral load in new mothers and newborns to enable same-day treatment decisions, the company said.
Designed for use on Cepheid's GeneXpert Systems, which provide polymerase chain-reaction testing on location at medical centers and hospitals, can deliver results within 90 minutes.
Upcoming Events
-
21Oct